Federal Register - May 7, 2021
Versione di testo Cosa è?Dateas è un sito indipendente non affiliato a entità governative. La fonte dei documenti PDF che pubblichiamo qui è l'entità governativa indicata in ciascuno di essi. Le versioni in testo sono trascrizioni che realizziamo per facilitare l'accesso e la ricerca di informazioni, ma possono contenere errori o non essere complete.
Source: Federal Register
24667
Federal Register / Vol. 86, No. 87 / Friday, May 7, 2021 / Notices The Drug Enforcement Administration DEA is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic classes of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA
registration.
DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefor, may file written comments on or objections to the issuance of the proposed registration on or before July 6, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia 22152. To ensure proper handling of comments, please reference Docket NoDEA814 in all correspondence, including attachments.
SUPPLEMENTARY INFORMATION: The Controlled Substances Act CSA
prohibits the cultivation and distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33a, DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic classes, and applicants therefor, may file written comments on or objections of the requested registration, as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted.
The applicant plans to manufacture bulk active pharmaceutical ingredients API for product development and distribution to DEA registered researchers. If the application for registration is granted, the registrant would not be authorized to conduct other activity under this registration aside from those coincident activities specifically authorized by DEA
regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place.
As this applicant has applied to become registered as a bulk manufacturer of marihuana, the application will be evaluated under the SUMMARY:
VerDate Sep<11>2014
19:55 May 06, 2021
Jkt 253001
criteria of 21 U.S.C. 823a. DEA will conduct this evaluation in the manner described in the rule published at 85 FR
82333 on December 18, 2020, and reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33a, DEA is providing notice that on March 2, 2021, Indian Flower LLC., 1104 North 105th East Avenue, Tulsa, Oklahoma 741161527, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
Drug code
Controlled substance Marihuana
Schedule
I 7360 II
William T. McDermott, Assistant Administrator.
FR Doc. 202109662 Filed 5621; 8:45 am BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Docket No. DEA832
Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Green Rush Organic Farms Inc.
Drug Enforcement Administration, Justice.
ACTION: Notice of application.
AGENCY:
The Drug Enforcement Administration DEA is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic classes of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA
registration.
DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefor, may file written comments on or objections to the issuance of the proposed registration on or before July 6, 2021.
ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW 8701
Morrissette Drive, Springfield, Virginia 22152. To ensure proper handling of comments, please reference Docket NoDEA832 in all correspondence, including attachments.
SUPPLEMENTARY INFORMATION: The Controlled Substances Act CSA
SUMMARY:
PO 00000
Frm 00086
Fmt 4703
Sfmt 9990
prohibits the cultivation and distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33a, DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic classes, and applicants therefor, may file written comments on or objections of the requested registration, as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted.
The applicant plans to manufacture bulk active pharmaceutical ingredients APIs for product development and distribution to DEA registered researchers. If the application for registration is granted, the registrant would not be authorized to conduct other activity under this registration aside from those coincident activities specifically authorized by DEA
regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place.
As this applicant has applied to become registered as a bulk manufacturer of marihuana, the application will be evaluated under the criteria of 21 U.S.C. 823a. DEA will conduct this evaluation in the manner described in the rule published at 85 FR
82333 on December 18, 2020, and reflected in DEA regulations at 21 CFR
part 1318.
In accordance with 21 CFR
1301.33a, DEA is providing notice that on March 31, 2021, Green Rush Organic Farms Inc., 1318 South Kilbourn Avenue, Chicago, Illinois 60623, applied to be registered as a bulk manufacturer of the following basic classes of controlled substances:
Marihuana Extract
Marihuana
Tetrahydrocannabinols
7350
7360
7370
I
I
I
William T. McDermott, Assistant Administrator.
FR Doc. 202109663 Filed 5621; 8:45 am BILLING CODE P
E:FRFM07MYN1.SGM
07MYN1
